[HTML][HTML] Leishmania infections: Molecular targets and diagnosis

M Akhoundi, T Downing, J Votýpka, K Kuhls… - Molecular aspects of …, 2017 - Elsevier
Progress in the diagnosis of leishmaniases depends on the development of effective
methods and the discovery of suitable biomarkers. We propose firstly an update …

Epidemiology of visceral leishmaniasis

PD Ready - Clinical epidemiology, 2014 - Taylor & Francis
Leishmania species are the causative agents of leishmaniasis, a neglected tropical disease.
These parasitic protozoans are usually transmitted between vertebrate hosts by the bite of …

Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans

AL Bañuls, M Hide, F Prugnolle - Advances in parasitology, 2007 - Elsevier
Leishmaniases remain a major public health problem today despite the vast amount of
research conducted on Leishmania pathogens. The biological model is genetically and …

Evolutionary and geographical history of the Leishmania donovani complex with a revision of current taxonomy

J Lukeš, IL Mauricio, G Schönian… - Proceedings of the …, 2007 - National Acad Sciences
Leishmaniasis is a geographically widespread severe disease, with an increasing incidence
of two million cases per year and 350 million people from 88 countries at risk. The causative …

Molecular diagnosis of leishmaniasis: current status and future applications

R Reithinger, JC Dujardin - Journal of clinical microbiology, 2007 - Am Soc Microbiol
Leishmania parasites are the etiological agents of the leishmaniases. The parasites are
transmitted to mammals, including humans, by the bite of phlebotomine sand ffies and …

Molecular diagnosis of visceral leishmaniasis

S Sundar, OP Singh - Molecular diagnosis & therapy, 2018 - Springer
Visceral leishmaniasis (VL), a deadly parasitic disease, is a major public health concern
globally. Countries affected by VL have signed the London Declaration on Neglected …

Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent

H Imamura, T Downing, F Van den Broeck, MJ Sanders… - Elife, 2016 - elifesciences.org
Leishmania donovani causes visceral leishmaniasis (VL), the second most deadly vector-
borne parasitic disease. A recent epidemic in the Indian subcontinent (ISC) caused up to …

Influence of Leishmania (Viannia) Species on the Response to Antimonial Treatment in Patients with American Tegumentary Leishmaniasis

J Arevalo, L Ramirez, V Adaui, M Zimic… - The Journal of …, 2007 - academic.oup.com
Abstract Background. Pentavalent antimonials (SbV) are the first-line chemotherapy for
American tegumentary leishmaniasis (ATL). There are, however, reports of the occurrence of …

The molecular epidemiology and phylogeography of Trypanosoma cruzi and parallel research on Leishmania: looking back and to the future

MA Miles, MS Llewellyn, MD Lewis, M Yeo, R Baleela… - Parasitology, 2009 - cambridge.org
Trypanosoma cruzi is the protozoan agent of Chagas disease, and the most important
parasitic disease in Latin America. Protozoa of the genus Leishmania are global agents of …

Laboratory diagnosis of cutaneous and visceral leishmaniasis: current and future methods

JQ Reimão, EM Coser, MR Lee, AC Coelho - Microorganisms, 2020 - mdpi.com
Leishmaniasis is a neglected tropical disease with two main clinical forms: cutaneous and
visceral leishmaniasis. Diagnosis of leishmaniasis is still a challenge, concerning the …